Journal article
Thrombolysis ImPlementation in Stroke (TIPS): Evaluating the effectiveness of a strategy to increase the adoption of best evidence practice - protocol for a cluster randomised controlled trial in acute stroke care
CL Paul, CR Levi, CA D'Este, MW Parsons, CF Bladin, RI Lindley, JR Attia, F Henskens, E Lalor, M Longworth, S Middleton, A Ryan, E Kerr, RW Sanson-Fisher, C Anderson, I Bruce, H Buchan, C Burdusel, E Butler, G Cadigan Show all
Implementation Science | BMC | Published : 2014
Abstract
Background: Stroke is a leading cause of death and disability internationally. One of the three effective interventions in the acute phase of stroke care is thrombolytic therapy with tissue plasminogen activator (tPA), if given within 4.5 hours of onset to appropriate cases of ischaemic stroke.Objectives: To test the effectiveness of a multi-component multidisciplinary collaborative approach compared to usual care as a strategy for increasing thrombolysis rates for all stroke patients at intervention hospitals, while maintaining accepted benchmarks for low rates of intracranial haemorrhage and high rates of functional outcomes for both groups at three months.Methods and design: A cluster ran..
View full abstractGrants
Awarded by Boehringer Ingelheim
Funding Acknowledgements
This project is funded by the National Health and Medical Research Council (NHMRC) as a partnership grant (ID569328) and is part-funded by a TRIP fellowship, with collaborative funding from Boehringer Ingelheim and in-kind support from ACI Stroke Care Network/Stroke Services NSW, Victorian Stroke Clinical Network, National Stroke Foundation (NSF) and NSW Cardiovascular Research Network-National Heart Foundation, with infrastructure funding from Hunter Medical Research Institute (HMRI) and The University of Newcastle (UoN). The UoN is the coordinating centre, the TRIP fellowship funds the research activities for the Clinical Champion, Boehringer Ingelheim funds workshops, logistics and educational material, ACI Stroke Clinical Network/Stroke Services NSW and Victorian Stroke Clinical Network provide support for a stroke care coordinator's time collating and entering tPA audit results, and NSW Cardiovascular Research Network-National Heart Foundation provides support for the involvement of a clinical practice change expert to support quality improvement strategies at each site. The NHMRC partnership grant is covering the cost of the remaining project activities. Although the Industry Partner is a manufacturer of the tPA drug and therefore has a vested interest in increasing tPA rates, their involvement is subject to strict guidelines, including non-involvement in the study design, data collection, analysis and publications. The assistance of Kate Day and Kate Ross in progressing toward launching the study is gratefully acknowledged.